Evidence map›Paper›PMID 36271884›Full record

ReviewInflammatory bowel diseases2023

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.

Frank I Scott, Orna Ehrlich, Dallas Wood, Catherine Viator, Carrie Rains, Lisa DiMartino, Jill McArdle, Gabrielle Adams, Lara Barkoff, Jennifer Caudle and 7 more

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Inflammatory bowel diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Frank I ScottDivision of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-6021-0419
Orna EhrlichCrohn's & Colitis Foundation, New York, NY, USA.
Dallas WoodRTI International, Research Triangle Park, NC, USA.
Catherine ViatorRTI International, Research Triangle Park, NC, USA.
Carrie RainsRTI International, Research Triangle Park, NC, USA.
Lisa DiMartinoRTI International, Research Triangle Park, NC, USA.
Jill McArdleRTI International, Research Triangle Park, NC, USA.
Gabrielle AdamsSouthwest Gastroenterology, Albuquerque, NM, USA.
Lara BarkoffAlbuquerque, NM, USA.
Jennifer CaudleDepartment of Family Medicine, Rowan University School of Osteopathic Medicine, Sewell, NJ, USA.
Jianfeng ChengEverett Clinic, Everett, WA, USA.
Jami KinnucanSection of Gastroenterology and Hepatology Mayo Clinic, Jacksonville, FL, USA.
Kimberly PersleyGI Alliance Gastroenterologist Presbyterian, Dallas, TX, USA.
Jennifer SariegoPenn Medicine At Home, University of Pennsylvania Health System, Bala Cynwd, PA, USA.
Samir ShahDivision of Gastroenterology, Brown University, Providence, RI, USA.
Caren HellerCrohn's & Colitis Foundation, New York, NY, USA.
David T RubinInflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.ORCID 0000-0001-5647-1723
RTI International · USCrohn's and Colitis Foundation · USBrown University · USEverett Community College · USJacksonville College · USRadiology Associates of Albuquerque · USRowan University · USTexas Health Dallas · USUniversity of Chicago · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecommendations regarding signs and symptoms that should prompt referral of patients with inflammatory bowel disease (IBD) to an IBD specialist for a consultation could serve to improve the quality of care for these patients. Our aim was to develop a consult care pathway consisting of clinical features related to IBD that should prompt appropriate consultation.

methodsA scoping literature review was performed to identify clinical features that should prompt consultation with an IBD specialist. A panel of 11 experts was convened over 4 meetings to develop a consult care pathway using the RAND/UCLA Appropriateness Method. Items identified via scoping review were ranked and were divided into major and minor criteria. Additionally, a literature and panel review was conducted assessing potential barriers and facilitators to implementing the consult care pathway.

resultsOf 43 features assessed, 13 were included in the care pathway as major criteria and 15 were included as minor criteria. Experts agreed that stratification into major criteria and minor criteria was appropriate and that 1 major or 2 or more minor criteria should be required to consider consultation. The greatest barrier to implementation was considered to be organizational resource allocation, while endorsements by national gastroenterology and general medicine societies were considered to be the strongest facilitator.

conclusionsThis novel referral care pathway identifies key criteria that could be used to triage patients with IBD who would benefit from IBD specialist consultation. Future research will be required to validate these findings and assess the impact of implementing this pathway in routine IBD-related care.

Indexed as

GastroenterologyInflammatory Bowel DiseasesHumansReferral and Consultationcare referral pathwayIBD specialist consultationinflammatory bowel disease

Identifiers

PMID36271884
PMCPMC10393070
OpenAlexW4307092486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.